Multimeric proteins and methods of making and using same

Details for Australian Patent Application No. 2002365196 (hide)

Owner Perlan Therapeutics, Inc.

Inventors Fang, Fang; Kohlstaedt, Lori Allison; Luo, Guang-Xiang; Charles, Cathrine Helen

Agent Shelston IP

Pub. Number AU-B-2002365196

PCT Number PCT/US02/23003

PCT Pub. Number WO2003/062370

Priority 60/335,425 30.11.01 US; 60/306,746 19.07.01 US

Filing date 19 July 2002

Wipo publication date 2 September 2003

Acceptance publication date 15 January 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/335,425 30.11.01 US; 60/306,746 19.07.01 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2002365196

15 January 2009 Application Accepted

  Published as AU-B-2002365196

29 January 2009 Corrigenda

  Applications Accepted - Name Index Under the name Perlan Therapeutics, Inc., Application No. 2002365196, under INID(72), correct the co-inventor name to Charles, Catherine Helen

23 April 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 27 Mar 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2003

13 August 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 Mar 2009 2003

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365197-ACTIVATION EFFECT ON CARBON NANOTUBES

2002365195-INTRACELLULAR SIGNALING MOLECULES